Generic Drugs & Its Future In India
India’s generic drug debate centers on lowering healthcare costs and improving access. However, inconsistent quality standards, weak regulation, and unqualified pharmacy practices limit true benefits, making robust oversight crucial for sustainable adoption.
In the recent past, a lot of buzz is around generic drugs in India. The general discussion is about the reduction in the medicine cost. Most articles on this subject deal with two aspects. One is, the cost of nongeneric or branded medicine is much higher than the generic ones. Price of generic drugs is compared with ethically promoted and prescribed branded products. Comparison is placed to prove the point. Sales of the later products are indicated to be not so ethical by multiple logics. Drug price as the only significant differentiator is argued for reducing health care costs.
The second point is about making medical treatment available to a larger section of society. People below the poverty line struggle to take medical help. Government hospitals & PHCs treat patients free of cost. However, most often patients are asked to purchase drugs from the retail pharmacy. This becomes prohibitive for the economically challenged section of society. Generic drugs are likely to reduce this burden and more people can afford to take the benefit of health care by opting for generic drugs. This is the argument most commentators make in the recent debates.
In a popular TV show a couple of…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!